<table border="1" id="id_c5ee6171-99b2-4920-ad23-073fc8e22ebd" width="455.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_7aa42589-f65e-4309-9922-7c4703a5dfae">TABLE 1: SUMMARY OF EFFECTIVENESS DATA IN PLACEBO-CONTROLLED TRIALS</caption>
<col width="16.7%"></col>
<col width="7.5%"></col>
<col width="16.7%"></col>
<col width="15.8%"></col>
<col width="10.1%"></col>
<col width="18.9%"></col>
<col width="14.3%"></col>
<tbody>
<tr id="id_0f40b66c-3616-4fa6-b393-a8e129d7bf05">
<td align="left" rowspan="2" stylecode="Botrule Toprule Rrule Lrule" valign="middle">
<content stylecode="bold"> </content>
</td>
<td align="center" colspan="3" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">SYMPTOM SCORE</content>
<footnote id="id-ae4ef1ae-c3d1-4c37-b980-cedc345c004e">AUA questionnaire (range 0 to 30) in <content stylecode="bold">STUDIES 1</content> and <content stylecode="bold">3</content>. Modified Boyarsky Questionnaire (range 7 to 39) in<content stylecode="bold"> STUDY 2</content>.</footnote>
</td>
<td align="center" colspan="3" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">MAXIMUM FLOW RATE (mL/sec)</content>
<content stylecode="bold"> </content>
</td>
</tr>
<tr id="id_ede93d02-2ca1-45c3-8958-c581103be9a0">
<td align="center" stylecode="Lrule Botrule Rrule" valign="middle">
<content stylecode="bold">
<content stylecode="underline">N</content>
</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">MEAN </content>
<content stylecode="underline">
<content stylecode="bold">BASELINE</content>
</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">MEAN</content>
<content stylecode="bold">
<content stylecode="underline">CHANGE<footnote id="id-978d35b0-d9cd-4abc-917c-bdac3e37aaf6">Change is to endpoint.</footnote>
</content>
</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">
<content stylecode="underline">N</content>
</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">MEAN <content stylecode="underline">BASELINE</content>
</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">MEAN</content>
<content stylecode="bold">
<content stylecode="underline">CHANGE<footnote id="id-8cfa9f40-7d54-441d-a312-01afba178b5f">Change is fixed-dose efficacy phase, 22 to 26 hours post-dose for <content stylecode="bold">STUDIES 1</content> and <content stylecode="bold">3</content> and 2 to 6 hours post-dose for <content stylecode="bold">STUDY 2</content>.</footnote>
</content>
</content>
</td>
</tr>
<tr id="id_60f3dfc4-2a9d-40df-ae8e-d150ea50a259">
<td align="left" colspan="7" stylecode="Lrule Botrule Rrule" valign="middle">
<content stylecode="bold">STUDY 1 (Titration to maximum dose of 8 mg)</content>
<footnote id="id-b137bb31-328b-4021-9d5f-3a46c2e8185d">36 patients received a dose of 8 mg doxazosin mesylate.</footnote>
</td>
</tr>
<tr id="id_359bdd97-b2e5-4bb3-886b-577820d5a709">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Placebo</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">47</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">15.6</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">-2.3</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">41</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">9.7</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">+0.7</td>
</tr>
<tr id="id_8172113d-9123-4cf4-83f6-693c6e6c4e53">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Doxazosin mesylate</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">49</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">14.5</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">-4.9<footnote id="id-f4d0d4b4-2b59-47c6-abf4-c9280c1e9cfc">p &lt; 0.01 compared to placebo mean change.</footnote>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">41</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">9.8</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">+2.9<footnoteref idref="id-f4d0d4b4-2b59-47c6-abf4-c9280c1e9cfc"></footnoteref>
</td>
</tr>
<tr id="id_648bf769-fe66-417d-a0e1-181576e05392">
<td align="left" colspan="7" stylecode="Lrule Botrule Rrule" valign="middle">
<content stylecode="bold">STUDY 2 (Titration to fixed dose-14 weeks)</content>
<footnote id="id-d665f703-e671-49d8-8fbc-ae3473813690">Study in hypertensives with BPH.</footnote>
</td>
</tr>
<tr id="id_66f00296-63d0-4afd-8472-c3e06c0dc133">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Placebo</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">37</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">20.7</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">-2.5</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">30</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">10.6</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">+0.1</td>
</tr>
<tr id="id_bdbb17e1-e172-47ec-a480-b0b819e69d3e">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Doxazosin mesylate 4 mg</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">38</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">21.2</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">-5.0<footnoteref idref="id-f4d0d4b4-2b59-47c6-abf4-c9280c1e9cfc"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">32</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">9.8</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">+2.3<footnote id="id-99fc4c11-b7a6-4897-9b4e-cf6de9213be2">p &lt; 0.05 compared to placebo mean change.</footnote>
</td>
</tr>
<tr id="id_ea4b4ffb-f954-4180-b706-7b2cbfc4187e">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Doxazosin mesylate 8 mg</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">42</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">19.9</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">-4.2<footnoteref idref="id-99fc4c11-b7a6-4897-9b4e-cf6de9213be2"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">36</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">10.5</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">+3.3<footnoteref idref="id-f4d0d4b4-2b59-47c6-abf4-c9280c1e9cfc"></footnoteref>
</td>
</tr>
<tr id="id_f7b1df3c-64aa-406e-b66d-350612cfe59a">
<td align="left" colspan="7" stylecode="Lrule Botrule Rrule" valign="top">
<content stylecode="bold">STUDY 3 (Titration to fixed dose-12 weeks)</content>
</td>
</tr>
<tr id="id_c5a6be2b-8203-4b7e-bf12-34e762d01854">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">Placebo </td>
<td align="left" stylecode="Botrule Rrule" valign="top"> 47</td>
<td align="left" stylecode="Botrule Rrule" valign="top"> 14.9</td>
<td align="left" stylecode="Botrule Rrule" valign="top"> -4.7</td>
<td align="left" stylecode="Botrule Rrule" valign="top"> 44</td>
<td align="left" stylecode="Botrule Rrule" valign="top"> 9.9</td>
<td align="left" stylecode="Botrule Rrule" valign="top"> +2.1</td>
</tr>
<tr id="id_55778245-970c-4f50-898d-3a762633d528">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">Doxazosin mesylate 4 mg</td>
<td align="left" stylecode="Rrule" valign="top"> 46</td>
<td align="left" stylecode="Rrule" valign="top"> 16.6</td>
<td align="left" stylecode="Rrule" valign="top"> -6.1<footnoteref idref="id-99fc4c11-b7a6-4897-9b4e-cf6de9213be2"></footnoteref>
</td>
<td align="left" stylecode="Rrule" valign="top"> 46</td>
<td align="left" stylecode="Rrule" valign="top"> 9.6</td>
<td align="left" stylecode="Botrule Rrule" valign="top"> +2.6</td>
</tr>
</tbody>
</table>